Page 2 - அமைச்சகம் ஆஃப் ஆரோக்கியம் ரஷ்யா ஆன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India to decide emergency use authorisation of Sputnik V

India to decide emergency use authorisation of Sputnik V
russiaherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from russiaherald.com Daily Mail and Mail on Sunday newspapers.

New delhiHarsh vardhanUnion healthGamaleya national research institute of epidemiologyMeeting of subject expert committeeLung instituteCentral drugs standard control organisationMinistry of health russia onRussian direct investment fundSubject expert committeeUnion health minister harsh vardhanDelhi heartGamaleya national research instituteபுதியது டெல்ஹிகடுமையான வர்தன்தொழிற்சங்கம் ஆரோக்கியம்

COVID-19: India to decide emergency use authorisation of Sputnik V COVID-19 vaccine today

COVID-19: India to decide emergency use authorisation of Sputnik V COVID-19 vaccine today
indiatvnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatvnews.com Daily Mail and Mail on Sunday newspapers.

Harsh vardhanUnion healthGamaleya national research institute of epidemiologyMeeting of subject expert committeeLung instituteCentral drugs standard control organisationMinistry of health russia onRussian direct investment fundImage sourceSubject expert committeeUnion health minister harsh vardhanDelhi heartGamaleya national research instituteகடுமையான வர்தன்தொழிற்சங்கம் ஆரோக்கியம்சந்தித்தல் ஆஃப் பொருள் நிபுணர் குழு

COVID-19: India to decide emergency use authorisation of Sputnik V vaccine today

COVID-19: India to decide emergency use authorisation of Sputnik V vaccine today
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.

Sputnik V | Expert panel reviews EUA application for Sputnik V vaccine; seeks immunogenicity, safety data

Sputnik V has demonstrated an efficacy rate of 91.6 per cent in the interim analysis of its phase 3 clinical trial, which includes data on 19,866 volunteers in Russia.

New delhiCentral drug authority onGamaleya national research institute of epidemiologySerum institute of indiaExpert committeeMinistry of health russia onRussian direct investment fundPhoto creditCentral drug authoritySubject expert committeeHyderabad based bharat biotechHyderabad based dr reddyDrugs controller generalBharat biotechSerum instituteGamaleya national research institute

Expert panel reviews emergency use application for Sputnik V vaccine; seeks immunogenicity, safety d- The New Indian Express

Expert panel reviews emergency use application for Sputnik V vaccine; seeks immunogenicity, safety d- The New Indian Express
newindianexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newindianexpress.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshGamaleya national research institute of epidemiologySerum institute of indiaExpert committeeIndia central drug authorityMinistry of health russia onRussian direct investment fundCentral drug authoritySubject expert committeeHyderabad based bharat biotechDrugs controller generalBharat biotechSerum instituteGamaleya national research instituteஆந்திரா பிரதேஷ்சீரம் நிறுவனம் ஆஃப் இந்தியா